Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
zomedica已推出第三款以马为焦点的检测产品——用于Truforma In-Clinic生物传感器测试平台的马血清胰岛素检测
- Veterinarians test equine insulin levels when they suspect Equine Metabolic Syndrome (EMS) or other forms of insulin dysregulation, as frequently occurs with equine Cushing's disease, or Pituitary Pars Intermedia Dysfunction (PPID), with prevalence reported between 18-27% of ponies and horses. Left untreated, laminitis, which can lead to euthanasia, is a consequence of both EMS and PPID.
- The TRUFORMA Insulin assay offers quantitative detection of insulin levels in equine plasma, with results available in just 18 minutes. This rapid turnaround enables veterinarians to diagnose and monitor insulin dysregulation in horses quickly, eliminating the need for reference laboratory wait times and allowing for immediate treatment decisions. The assay is designed for both in-clinic and stall-side use, providing flexibility for various clinical settings. Importantly, Zomedica offers this advanced diagnostic capability with no capital outlay or monthly minimums from veterinary practices.
- 兽医在怀疑马匹代谢综合症（EMS）或其他类型的胰岛素失调时，会检测马匹的胰岛素水平，这种情况常见于马匹库欣病或垂体中间部功能障碍（PPID），在小型马和马中的患病率报告为18-27%。如果不加以治疗，LAMINITIS（蹄叶炎）可能会导致安乐死，这是EMS和PPID的结果。
- TRUFORMA胰岛素测定提供对马匹血浆中胰岛素水平的定量检测，结果仅需18分钟即可获得。这一快速的检测结果使兽医能够迅速诊断和监测马匹的胰岛素失调，消除了对参考实验室等待时间的需求，并允许立即做出治疗决定。该测定设计用于临床和马厩旁的使用，为各种临床环境提供灵活性。值得注意的是，zomedica提供这种爱文思控股的诊断能力，无需兽医实践的资本支出或月最低要求。
资讯热榜
更新时间